SUNREST

Sunrest Lifescience Share Price

 

 

Start SIP in SUNREST

Start SIP

Performance

  • Low
  • ₹44
  • High
  • ₹49
  • 52 Week Low
  • ₹30
  • 52 Week High
  • ₹61
  • Open Price₹44
  • Previous Close₹44
  • Volume38,400
  • 50 DMA₹40.65
  • 100 DMA₹45.31
  • 200 DMA₹51.77

Investment Returns

  • Over 1 Month + 43.93%
  • Over 3 Month + 2.67%
  • Over 6 Month -9.85%
  • Over 1 Year -24.26%

Smart Investing Starts Here Start SIP with Sunrest Lifescience for Steady Growth!

Invest Now

Sunrest Lifescience Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 9.9
  • PEG Ratio
  • -
  • Market Cap Cr
  • 20
  • P/B Ratio
  • 1.2
  • Average True Range
  • 2.85
  • EPS
  • 4.67
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.79
  • RSI
  • 66.6
  • MFI
  • 83.89

Sunrest Lifescience Financials

Sunrest Lifescience Technicals

EMA & SMA

Current Price
₹46.20
+ 2.4 (5.48%)
pointer
  • Bearish Moving Average 4
  • Bullish Moving Average 12
  • 20 Day
  • ₹37.59
  • 50 Day
  • ₹40.65
  • 100 Day
  • ₹45.31
  • 200 Day
  • ₹51.77

Resistance and Support

46.23 Pivot Speed
  • R3 54.47
  • R2 51.73
  • R1 48.97
  • S1 43.47
  • S2 40.73
  • S3 37.97

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Sunrest Lifescience Ltd has an operating revenue of Rs. 67.42 Cr. on a trailing 12-month basis. An annual revenue growth of 12% is good, Pre-tax margin of 8% is okay, ROE of 12% is good. The company has a reasonable debt to equity of 35%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 81 which is a GOOD score indicating consistency in earnings, a RS Rating of 41 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 55 indicates it belongs to a fair industry group of Medical-Supplies and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Sunrest Lifescience Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-19 Fund Raising & Others To consider other business matters.
2026-02-13 Fund Raising & Others To consider other business matters.
2025-11-13 Quarterly Results
2025-05-30 Audited Results (Revised)
2024-11-14 Quarterly Results

Sunrest Lifescience F&O

Sunrest Lifescience Shareholding Pattern

53.5%
34.9%
11.6%

About Sunrest Lifescience

  • NSE Symbol
  • SUNREST
  • BSE Symbol
  • Managing Director
  • Mr. Nikhilkumar Yashvntlal Thakkar
  • ISIN
  • INE0PLZ01012

Similar Stocks to Sunrest Lifescience

Sunrest Lifescience FAQs

Sunrest Lifescience share price is ₹46 As on 20 February, 2026 | 09:00

The Market Cap of Sunrest Lifescience is ₹19.8 Cr As on 20 February, 2026 | 09:00

The P/E ratio of Sunrest Lifescience is 9.9 As on 20 February, 2026 | 09:00

The PB ratio of Sunrest Lifescience is 1.2 As on 20 February, 2026 | 09:00

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23